Harbor Capital Advisors Inc. Grows Holdings in Acadia Healthcare Company, Inc. (NASDAQ:ACHC)

Harbor Capital Advisors Inc. grew its position in shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC - Free Report) by 302.0% during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 90,772 shares of the company's stock after buying an additional 68,190 shares during the quarter. Harbor Capital Advisors Inc. owned 0.10% of Acadia Healthcare worth $3,599,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds and other institutional investors have also recently modified their holdings of ACHC. GAMMA Investing LLC lifted its holdings in Acadia Healthcare by 57.1% during the third quarter. GAMMA Investing LLC now owns 663 shares of the company's stock worth $42,000 after acquiring an additional 241 shares during the period. Point72 Asia Singapore Pte. Ltd. bought a new stake in shares of Acadia Healthcare during the 2nd quarter worth $59,000. Covestor Ltd raised its stake in shares of Acadia Healthcare by 834.4% during the 3rd quarter. Covestor Ltd now owns 1,140 shares of the company's stock worth $72,000 after purchasing an additional 1,018 shares during the period. DekaBank Deutsche Girozentrale bought a new position in Acadia Healthcare during the third quarter valued at about $86,000. Finally, Assetmark Inc. increased its holdings in Acadia Healthcare by 66.1% during the third quarter. Assetmark Inc. now owns 1,485 shares of the company's stock worth $94,000 after buying an additional 591 shares during the last quarter.

Wall Street Analyst Weigh In

A number of research analysts have weighed in on the stock. StockNews.com cut shares of Acadia Healthcare from a "hold" rating to a "sell" rating in a research note on Monday, January 6th. TD Cowen reduced their price objective on Acadia Healthcare from $70.00 to $66.00 and set a "buy" rating for the company in a report on Tuesday. Cantor Fitzgerald restated a "neutral" rating and issued a $52.00 target price on shares of Acadia Healthcare in a research note on Tuesday, December 10th. Deutsche Bank Aktiengesellschaft upgraded Acadia Healthcare from a "hold" rating to a "buy" rating and increased their price target for the stock from $45.00 to $75.00 in a research note on Thursday, December 12th. Finally, Barclays lowered their price objective on Acadia Healthcare from $76.00 to $43.00 and set an "overweight" rating on the stock in a research note on Friday, November 22nd. One analyst has rated the stock with a sell rating, two have given a hold rating and seven have given a buy rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and a consensus price target of $70.22.

Acadia Healthcare Price Performance

Shares of ACHC stock traded down $0.20 during trading hours on Friday, reaching $44.92. The stock had a trading volume of 1,930,656 shares, compared to its average volume of 2,303,759. The stock's fifty day simple moving average is $40.54 and its 200 day simple moving average is $57.96. The firm has a market capitalization of $4.17 billion, a PE ratio of 14.73, a PEG ratio of 1.77 and a beta of 1.29. Acadia Healthcare Company, Inc. has a 12 month low of $36.50 and a 12 month high of $87.77. The company has a current ratio of 1.07, a quick ratio of 1.07 and a debt-to-equity ratio of 0.60.

Acadia Healthcare (NASDAQ:ACHC - Get Free Report) last announced its quarterly earnings results on Wednesday, October 30th. The company reported $0.91 EPS for the quarter, beating the consensus estimate of $0.90 by $0.01. Acadia Healthcare had a net margin of 8.99% and a return on equity of 11.12%. The firm had revenue of $815.60 million during the quarter, compared to the consensus estimate of $819.42 million. During the same period last year, the firm earned $0.91 EPS. The business's quarterly revenue was up 8.7% compared to the same quarter last year. On average, equities research analysts predict that Acadia Healthcare Company, Inc. will post 3.38 EPS for the current year.

Acadia Healthcare Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.